跳轉至內容
Merck
全部照片(1)

重要文件

M-020

Supelco

S(+)-甲基苯丙胺标准液 溶液

1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

同義詞:

右旋甲基苯丙胺

登入查看組織和合約定價


About This Item

經驗公式(希爾表示法):
C10H15N
CAS號碼:
分子量::
149.23
MDL號碼:
分類程式碼代碼:
41116107
PubChem物質ID:
NACRES:
NA.24
暫時無法取得訂價和供貨情況

等級

certified reference material

品質等級

形狀

liquid

特點

Snap-N-Spike®/Snap-N-Shoot®

包裝

ampule of 1 mL

製造商/商標名

Cerilliant®

drug control

Narcotic Licence Schedule A (Switzerland); psicótropo (Spain); Decreto Lei 15/93: Tabela IIB (Portugal)

濃度

1.0 mg/mL in methanol

技術

gas chromatography (GC): suitable
liquid chromatography (LC): suitable

應用

forensics and toxicology

形式

single component solution

儲存溫度

2-8°C

SMILES 字串

CN[C@@H](C)Cc1ccccc1

InChI

1S/C10H15N/c1-9(11-2)8-10-6-4-3-5-7-10/h3-7,9,11H,8H2,1-2H3/t9-/m0/s1

InChI 密鑰

MYWUZJCMWCOHBA-VIFPVBQESA-N

基因資訊

一般說明

甲基苯丙胺是苯乙胺和苯丙胺类的精神刺激药。 这种SNAP-N-Spike®参考溶液以街头名称“meth”,“冰”和“玻璃”而闻名,适用于LC/MS或GC/MS应用,包括临床毒理学,运动测试,法医分析或尿液药物测试。甲基苯丙胺的右旋异构体是一种药物,以商品名Desoxyn®出售,用于治疗ADHD和肥胖症。

法律資訊

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
Desoxyn is a registered trademark of Abbott Laboratories Corp.
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

相關產品

產品號碼
描述
訂價

訊號詞

Danger

危險分類

Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1

標靶器官

Eyes

儲存類別代碼

3 - Flammable liquids

水污染物質分類(WGK)

WGK 1

閃點(°F)

49.5 °F - closed cup

閃點(°C)

9.7 °C - closed cup


從最近期的版本中選擇一個:

分析證明 (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如果您需要協助,請聯絡 客戶支援

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

Diane M Herbeck et al.
Journal of psychoactive drugs, 45(2), 132-140 (2013-08-03)
This study examines health and legal problems associated with use of commonly reported substances and combinations of substances in a sample of adults with long histories of methamphetamine (meth) use. Data are from a 2009-11 eight-year follow-up interview in an
Adam Kelly
Emergency medicine journal : EMJ, 30(4), 339-340 (2013-03-21)
A short-cut review was carried out to establish which clinical parameters are useful in predicting outcome in patients who present having body packed metamphetamine. Eleven papers were found using the reported searches, of which one presented the best evidence to
New Meth vaccine shows promise in animals.
Human vaccines & immunotherapeutics, 9(1), 9-10 (2013-04-10)
Brett A Dolezal et al.
Journal of addiction medicine, 7(2), 122-128 (2013-04-05)
Physical exercise has been shown to benefit diverse medical and behavioral conditions. This study assesses the feasibility and efficacy of an 8-week endurance and resistance training program on fitness measures in individuals undergoing residential treatment for methamphetamine (MA) dependence. A
Glen R Hanson et al.
The Journal of pharmacology and experimental therapeutics, 346(2), 173-181 (2013-05-21)
Because of persistent social problems caused by methamphetamine (METH), new therapeutic strategies need to be developed. Thus, we investigated the response of central nervous system neurotensin (NT) systems to METH self-administration (SA) and their interaction with basal ganglia dopamine (DA)

條款

Optimized sample prep and chiral chromatography methods for the LC/MS analysis of these drug enantiomers in urine

In this study, optimized methods are presented for sample preparation and chiral chromatography for the LC/MS analysis of amphetamine and methamphetamine enantiomers in urine.

Questions

Reviews

No rating value

Active Filters

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務